EXPERT OPINION ON ORPHAN DRUGS
Publisher information is not available.
Identifiers, indexing coverage, and citation metrics for the academic journal EXPERT OPINION ON ORPHAN DRUGS. Identifiers: ISSN 2167-8707, eISSN 2167-8707. Subject areas: Pharmacology & Pharmacy. tlooto lists 809 papers from this journal.
CiteScore
-
Scopus citation metric
SJR
-
SCImago rank
SNIP
-
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 2167-8707
- eISSN
- 2167-8707
- Abbreviation
- -
- Publisher
- -
- Country
- -
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
No ASJC category data available.
Keywords
Pharmacology & Pharmacy
Papers in this journal
Recent papers
- Management of pulmonary hypertension in infants
2024 · 1 citations
- Current and emerging therapies for the treatment of leishmaniasis
2024 · 40 citations
- Emerging therapies against Naegleria fowleri
2024 · 8 citations
- Orphan drugs approved in Canada: health technology assessment, price negotiation, and government formulary listing
2024 · 6 citations
- The Orphan Drug Act and rare cancers: a retrospective analysis of oncologic orphan drug designations and associated approvals from 1983-2022
2024 · 3 citations
Most cited papers
- Orphan drugs and rare diseases: a scientometric review (2000 – 2014)
2014 · 204 citations
- Pseudoxanthoma elasticum: diagnostic features, classification and treatment options
2014 · 91 citations
- Pathogenesis, Emerging therapeutic targets and Treatment in Sialidosis
2015 · 71 citations
- Diagnosis, prevalence, and screening of familial dilated cardiomyopathy
2015 · 66 citations
- Leishmaniasis: treatment, drug resistance and emerging therapies
2018 · 65 citations